RS130-180

• Description :

  RS130-180 is a selective β-arrestin-biased agonist targeting the serotonin 2A receptor (5-HT2aR) . RS130-180 is promising for research of neuropsychiatric disorders such as depression[1].

• UNSPSC :

  12352211

• Target :

  5-HT Receptor

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Field of Research :

  Neurological Disease

• Smiles :

  C#CCOC1=C(C=CC=C1)CNCCC2=CC(OC)=C(C=C2OC)N(C)C

• Molecular Formula :

  C22H28N2O3

• Molecular Weight :

  368.47

• References & Citations :

  [1]Ali S, et al. Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond. J Med Chem. 2025 May 22;68 (10) :9831-9835.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  5-HT2 Receptor